We are live on ! Find out more
HFCIV

H&F Corporate Investors VIII Portfolio holdings

AUM $133M
1-Year Est. Return 24.42%
This Fund
S&P 500
This Quarter Est. Return
+0.74%
1 Year Est. Return
-24.42%
3 Year Est. Return
-33.78%
5 Year Est. Return
-50.35%
10 Year Est. Return
AUM
$1.69B
AUM Growth
-$135M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 69.95%
2 Technology 30.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTEV
1
Claritev Corp
CTEV
$652M
$1.18B 69.95%
5,387,862
SNPO
2
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
$508M 30.05%
55,424,435

Similar funds

H&F Corporate Investors VIII's Q2 2022 Portfolio in Review

As of Q2 2022, H&F Corporate Investors VIII held 2 positions worth $1.69B, down 7.4% from $1.83B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. H&F Corporate Investors VIII opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 55% a quarter earlier, followed by Technology.

  • H&F Corporate Investors VIII's ten largest holdings make up 100% of its $1.69B portfolio in Q2 2022.
  • H&F Corporate Investors VIII opened 0 new positions and closed 0 in Q2 2022.
  • H&F Corporate Investors VIII's portfolio value fell 7.4% quarter-over-quarter to $1.69B.

Based on H&F Corporate Investors VIII's 13F filing for Q2 2022, filed 9 Aug 2022.